Titleist is launching its new 2025 T-Series iron lineup with five new models. Here are seven things to know about the new ...

Taiwanese smart-scooter pioneer Gogoro is taking a step into more accessible territory with its newest model, the Ezzy. The ...

MightyFly’s Cento aircraft executed a DoD-relevant mission, demonstrating autonomous flight, cargo loading, unloading, and ...

The Cybertruck is quite heavy mainly because of its unique “ultra-hard stainless-steel” body, which is very strong and dense. Also, its large battery pack, especially the advanced 4680 battery cells, ...

Rumor mill: AMD's Navi 44 "RDNA 4" GPU is rumored to feature a significantly smaller package size compared to Navi 33, the smallest GPU in the Radeon RX 7000 series. However, it will still be ...

Fire-Dex is excited to announce the launch of the RescuePro Package, a bundle designed to provide the right gear for non-structural calls.

AMD's next-generation Zen 5-based Strix Halo APU arrives in FP11 package that's 60% bigger than Phoenix, same size as desktop Intel LGA1700 socket.

Joining Spectrum Control’s SCi Blocks RF portfolio is an RF front-end system-in-package (SiP) for next-generation defense systems. Customizable and digitally enabled, the RF+ SiP provides the ...

GSK and TESARO have entered into a definitive agreement concerning GSK's acquisition of TESARO for an aggregate cash consideration worth approximately $5.1 billion.

Tesaro (TSRO) has been a promising biotechnology company, at least in my eyes, and now in the eyes of GlaxoSmithKline (NYSE: GSK) as well. The British major pharmaceutical company has reached a ...

GlaxoSmithKline said it would buy cancer-focused drug company Tesaro for about $4.16 billion, positioning the health-care giant in a promising, but fiercely competitive, area of medicine.

The pharma giant GlaxoSmithKline just acquired the cancer-drug maker Tesaro for $5.1 billion in a bid to bulk up its cancer pipeline.